Company Filing History:
1 out of 121 
1 out of 336 
Years Active: 2025
Title: Colin Berry: Innovator in Microvascular Angina Diagnosis and Treatment
Introduction
Colin Berry is a notable inventor based in Strathclyde, GB. He has made significant contributions to the field of cardiology, particularly in the diagnosis and treatment of microvascular angina (MVA). His innovative approach has the potential to improve patient outcomes and enhance the understanding of this complex condition.
Latest Patents
Colin Berry holds a patent for his invention related to microvascular angina. The patent provides means of diagnosing and treating MVA. It includes diagnostic applications of intra-coronary guidewires and discloses the treatment of MVA patients with zibotentan. This invention allows for the identification and selection of MVA patients for treatment through the diagnostic applications provided. He has 1 patent to his name.
Career Highlights
Throughout his career, Colin Berry has worked with esteemed institutions such as the University of Glasgow and Cambridge Enterprise Limited. His work has been instrumental in advancing the understanding of microvascular angina and developing effective treatment strategies.
Collaborations
Colin Berry has collaborated with notable individuals in his field, including Thomas J Ford and Anthony Peter Davenport. These collaborations have contributed to the advancement of research and innovation in cardiology.
Conclusion
Colin Berry's contributions to the diagnosis and treatment of microvascular angina highlight his role as an innovator in the medical field. His work continues to influence the way MVA is understood and treated, paving the way for improved patient care.